MAEA and Miyoshi myopathy: The risk for progression to MM overall is higher for SBP (60–85% after 10 years) than for EMP (12–35% after 10 years), but it has been shown that the presence of a minimal infiltrate of clonal plasma cells in the BM detected by flow cytometry is associated with a strongly increased progression risk, although the risk remains lower for EMP.